New pill shows promise for Diabetes-Related vision loss
Disease control
Completed
This study tested an experimental oral medication called RZ402 in 94 adults with diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. The goal was to see if the drug is safe and can reduce swelling in the retina and improve eyesight compared …
Phase: PHASE2 • Sponsor: Rezolute • Aim: Disease control
Last updated May 17, 2026 11:37 UTC